VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $57,000 | +171.4% | 2,356 | +200.1% | 0.01% | +160.0% |
Q2 2022 | $21,000 | -67.7% | 785 | -53.3% | 0.01% | -58.3% |
Q1 2022 | $65,000 | +27.5% | 1,682 | +6.3% | 0.01% | +20.0% |
Q4 2021 | $51,000 | -44.0% | 1,582 | -48.8% | 0.01% | -47.4% |
Q3 2021 | $91,000 | +18.2% | 3,092 | +36.6% | 0.02% | +18.8% |
Q2 2021 | $77,000 | -56.2% | 2,263 | -58.2% | 0.02% | -59.0% |
Q1 2021 | $176,000 | -7.9% | 5,410 | +2.1% | 0.04% | -11.4% |
Q4 2020 | $191,000 | -50.1% | 5,298 | -78.9% | 0.04% | -54.6% |
Q3 2020 | $383,000 | +118.9% | 25,101 | +424.2% | 0.10% | +110.9% |
Q2 2020 | $175,000 | +59.1% | 4,788 | +0.6% | 0.05% | +27.8% |
Q1 2020 | $110,000 | -73.7% | 4,758 | -79.2% | 0.04% | -72.5% |
Q4 2018 | $419,000 | 0.0% | 22,850 | 0.0% | 0.13% | 0.0% |
Q3 2018 | $419,000 | -17.8% | 22,850 | 0.0% | 0.13% | -21.6% |
Q2 2018 | $510,000 | -82.3% | 22,850 | -81.6% | 0.17% | -82.6% |
Q4 2017 | $2,889,000 | – | 124,306 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |